POP1 promotes the progression of breast cancer through maintaining telomere integrity

Author:

Zhu Min1,Wu Chao1,Wu Xuan2,Song Ge2,Li Mingyang3ORCID,Wang Qiong4

Affiliation:

1. Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital , Beijing, 100853 , China

2. Department of Geriatrics, The Second Medical Center, Chinese PLA General Hospital , Beijing, 100853 , China

3. Department of Gastroenterology, The First Medical Center, Chinese PLA General Hospital , Beijing, 100853 , China

4. Department of Pathology, The First Medical Center, Chinese PLA General Hospital , Beijing, 100853 , China

Abstract

AbstractBreast cancer is one of the most common and disastrous neoplasm for women worldwide, especially triple-negative breast cancer (TNBC). Emerging evidences have demonstrated that RNase subunits are closely related to the occurrence and development of malignant tumors. However, the functions and underlying molecular mechanisms of Processing of Precursor 1 (POP1), a core component of RNase subunits, in breast cancer development have not been fully defined. Our study identified the POP1was upregulated in breast cancer cell lines and tissues and patients with higher POP1 expression were associated with poor outcomes. Overexpression of POP1 promoted cell progression in breast cancer cells, whereas silencing of POP1 induced cell cycle arrest. Moreover, Xenograft model reproduced its growth regulatory roles in breast cancer in vivo. Mechanistically, POP1 interacted and activated the telomerase complex by stabilizing the telomerase RNA component (TERC), thus protecting telomeres from shortening during division. Collectively, our findings demonstrate POP1 may as a novel prognostic marker and a therapeutic target for the management of breast cancer.

Funder

Mingyang Li

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Reference34 articles.

1. Cancer statistics, 2018;Siegel;CA. Cancer J. Clin.,2018

2. Breast cancer;Harbeck;Nat. Rev. Dis. Primers,2019

3. Breast cancer;Harbeck;Lancet,2017

4. Triple-negative breast cancer: disease entity or title of convenience?;Carey;Nat. Rev. Clin. Oncol.,2010

5. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment;Garrido-Castro;Cancer Discov.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3